GRAHAM DOCKRAY, Emeritus Professor of Physiology at the University of Liverpool, is welcomed as a new member of it’s scientific advisory board January 2013: TYG oncology Ltd registered – Companies House, UK.

DANIEL D. VON HOFF, M.D., F.A.C.P., a world renowned expert in the field of pancreatic advises the company on critical Phase 2 trial design.